Cargando…

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases

Anti-vascular endothelial growth factor (anti-VEGF) injections are the most effective treatment for exudative age-related macular degeneration (AMD). However, both bevacizumab and ranibizumab have been reported to cause submacular hemorrhage (SMH) in the treatment of exudative AMD. Aflibercept has a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoo, Chloe, Flynn, Erin, Sohal, Preet, Al Shabeeb, Rheem, El Khatib, Baha, Patronas, Marena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402395/ https://www.ncbi.nlm.nih.gov/pubmed/36039253 http://dx.doi.org/10.7759/cureus.27255

Ejemplares similares

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration
por: Shin, Kyung-Hoon, et al.
Publicado: (2016)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy
por: Vyas, Chinmayi Himanshuroy, et al.
Publicado: (2021)

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023)

Intravitreal Injection-Induced Migraine Headaches
por: Lerebours, Valerie C, et al.
Publicado: (2016)

Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study
por: Marques, João Pedro, et al.
Publicado: (2017)

Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
por: Weber, Constance, et al.
Publicado: (2022)

Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage
por: Abdul-Salim, Ismail, et al.
Publicado: (2013)

Traumatic Submacular Hemorrhage with Macular Hole Repaired by Pneumatic Displacement and Intravitreal t-PA Injection
por: Mehta, Amy A., et al.
Publicado: (2017)

The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection
por: Fugara, Nasser A, et al.
Publicado: (2022)

Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sandhu, Sukhpal Singh, et al.
Publicado: (2010)

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023)

Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report
por: Siotto Pintor, Emanuele, et al.
Publicado: (2023)

Immediate Rise in Intraocular Pressure After First-Time Intravitreal Injection of Bevacizumab
por: Mahar, Pir S, et al.
Publicado: (2023)

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
por: Mansour, Ahmad M., et al.
Publicado: (2020)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
por: Lee, Jung Pil, et al.
Publicado: (2016)

Intravitreal tPA Injection and Pneumatic Displacement for Submacular Hemorrhage in a 10-Year-Old Child
por: Tsuyama, Takayuki, et al.
Publicado: (2016)

Intravitreal r-tPA Injection and Pneumatic Displacement for Submacular Retinal Hemorrhage: A Case Series
por: Confalonieri, Filippo, et al.
Publicado: (2022)

Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study
por: Enoch, Jamie, et al.
Publicado: (2021)

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)

Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
por: Ahmed, Nasir, et al.
Publicado: (2021)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

Management of acute submacular hemorrhage using intravitreal injection of tissue plasminogen activator and gas: A case series
por: Karamitsos, Athanasios, et al.
Publicado: (2020)

Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration
por: Helaiwa, Khaled, et al.
Publicado: (2020)

Aflibercept as a Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis
por: Ramirez Marquez, Estefania, et al.
Publicado: (2022)

Aflibercept for the Treatment of Macular Edema Secondary to Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome
por: López Fontanet, José, et al.
Publicado: (2023)

Complication associated with intravitreal injection of tissue plasminogen activator for treatment of submacular hemorrhage due to rupture of retinal arterial macroaneurysm
por: Tsuiki, Eiko, et al.
Publicado: (2019)

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
por: Kitagawa, Yorihisa, et al.
Publicado: (2022)

Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages
por: Rickmann, Annekatrin, et al.
Publicado: (2021)

Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2014)

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
por: Kitahashi, Masayasu, et al.
Publicado: (2014)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis
por: Kong, Qihang, et al.
Publicado: (2021)

Successful delivery of subretinal aflibercept (new surgical technique) for the treatment of submacular hemorrhage in idiopathic polypoidal choroidal vasculopathy
por: Chalam, K V, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_60ests0qpa27ccd9h234l5q0j4